A decade of increases in Medicare Part B pharmaceutical spending: what are the drivers?

A decade of increases in Medicare Part B pharmaceutical spending: what are the drivers?

BACKGROUND: Medicare Part B pharmaceutical spending has increased rapidly, more than doubling in 2006-2017. Yet, it is unclear whether this increase was driven by increased utilization or increased cost per claim. OBJECTIVE: To evaluate the relative impact of changes in drug utilization and cost per...

Full description

Bibliographic Details
Main Authors: Gellad, W.F (Author), Good, C.B (Author), Hernandez, I. (Author), San-Juan-Rodriguez, A. (Author), Shrank, W.H (Author)
Format: Article
Language:English
Published: Academy of Managed Care Pharmacy (AMCP) 2021
Subjects:
antiemetic agent
antineoplastic agent
antirheumatic agent
Article
blood clotting factor
cost control
drug classification
drug cost
Drug Costs
drug utilization
Drug Utilization
economics
gastrointestinal agent
health care cost
Health Expenditures
Healthcare Common Procedure Coding System
hemostatic agent
human
Humans
immunologic agent
immunosuppressive agent
insurance
Insurance Claim Review
medicare
Medicare Part B
outcome assessment
quantitative analysis
Retrospective Studies
retrospective study
sensitivity analysis
United States
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items